Lexaria Bioscience

Lexaria Bioscience: Revolutionizing GLP-1 Drug Delivery with Patented Oral Platform
Healthcare

Lexaria Bioscience is setting new standards in drug delivery with its patented DehydraTECH™ oral technology, optimizing absorption for GLP-1 and other high-demand drugs.

November 28, 2024
Lexaria Bioscience: Advancing GLP-1 Drug Delivery with Hydrotec Technology
Healthcare

Lexaria Bioscience’s DehydraTECH™ technology aims to redefine oral drug delivery, focusing on faster absorption and improved efficacy, with a promising impact on the GLP-1 pharmaceutical market.

November 26, 2024
BTV Features these Stocks to Watch: Contango Ore, First Nordic Metals, Champion Iron, Prime Mining, Lexaria Bioscience, Osisko Development, West Red Lake Gold Mines, & Surge Battery Metals
BTV

On FOX Business News broadcast on Sunday, Dec 1, 2024 – BTV Business Television interviews emerging companies in the markets including:

November 26, 2024
Lexaria Bioscience: Transforming GLP-1 Drug Delivery for a Growing Market
Healthcare

Lexaria Bioscience is advancing GLP-1 drug delivery, aiming to improve effectiveness and reduce side effects for this fast-growing market.

September 20, 2024